Efficacy of interferon alpha 2a in 18 versus 60 months of treatment in patients with primary melanoma of ≥ 1.5 mm tumor thickness: A randomized phase III DeCOG trial
Hauschild, A., Volkenandt, M., Tilgen, W., Linse, R., Böttjer, J., Vogt, T., Spieth, K., Eigentler, T.
, Brockmeyer, N. H. and Weichenthal, M.
(2008)
Efficacy of interferon alpha 2a in 18 versus 60 months of treatment in patients with primary melanoma of ≥ 1.5 mm tumor thickness: A randomized phase III DeCOG trial.
Journal of Clinical Oncology 26 (15_sup), p. 9032.
Date of publication of this fulltext: 19 Dec 2024 13:19
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Clinical Oncology | ||||
| Publisher: | AMER SOC CLINICAL ONCOLOGY | ||||
|---|---|---|---|---|---|
| Place of Publication: | ALEXANDRIA | ||||
| Volume: | 26 | ||||
| Number of Issue or Book Chapter: | 15_sup | ||||
| Page Range: | p. 9032 | ||||
| Date | 2008 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 68129 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric